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Abstract In forensic casework analysis, identification of
the biological matrix and the species of a forensic trace,
preferably without loss of DNA, is of major importance. The
biological matrices that can be encountered in a forensic
context are blood (human or non-human), saliva, semen,
vaginal fluid, and to a lesser extent nasal secretions, feces,
and urine. All these matrices were applied on swabs and
digested with trypsin in order to obtain peptides. These
peptides were injected on a mass spectrometer (ESI Q-
TOF) resulting in the detection of several biomarkers that
were used to build a decision tree for matrix identification.
Saliva and blood were characterized by the presence of
alpha-amylase 1 and hemoglobin, respectively. In vaginal
fluid, cornulin, cornifin, and/or involucrin were found as
biomarkers while semenogelin, prostate-specific antigen,
and/or acid phosphatase were characteristic proteins for
semen. Uromodulin or AMBP protein imply the presence
of urine, while plunc protein is present in nasal secretions.
Feces could be determined by the presence of immunoglo-
bulins without hemoglobin. The biomarkers for the most
frequently encountered biological matrices (saliva, blood,
vaginal fluid, and semen) were validated in blind experi-
ments and on real forensic samples. Additionally, by means
of this proteomic approach, species identification was pos-
sible. This approach has the advantage that the analysis is
performed on the first “washing” step of the chelex DNA
extraction, a solution which is normally discarded, and that
one single test is sufficient to determine the identity and the
species of the biological matrix, while the conventional
methods require cascade testing. This technique can be
considered as a useful additional tool for biological matrix
identification in forensic science and holds the promise of
further automation.
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Introduction
In forensic science, DNA typing and fingerprint analysis are
the most prominent means for identifying individuals in-
volved in a crime. However, determining the biological
origin of a trace can be equally important in reconstructing
the events that took place. For example, when a suspect
accused of unwanted internal groping denies charges, the
presence of vaginal fluid under his fingernails can help in
pinpointing the suspect.
The biological matrices that are most often found at a
crime scene are blood, semen, vaginal fluid, and saliva. Less
frequently, other matrices such as nasal secretion, urine, and
feces can also be found. Biochemical tests that can deter-
mine whether biological fluids are present and that can
identify the matrix are already available. For example, blood
is detected by means of luminol or benzidine [1, 2]. For
semen, forensic tests currently focus on semenogelin, pros-
tatic acid phosphatase, and prostate-specific antigen (PSA)
(RSID-Semen test, Phosphatesmo Km Paper, and Seratec
PSA semiquant, respectively) [3–7]. The acid phosphatase
test, however, is an indirect test measuring enzyme activity.
When these tests were compared, PSA detection (Seratec
PSA semiquant test) gave the best results with constant
satisfactory sensitivity over time [5]. Alpha-amylase tests
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such as the Phadebas assay are currently available for the
detection of saliva. The latter is based on Bio-Degradable
Starch Microspheres which are covalently bound to a blue
dye. When alpha-amylase is present in a sample, the dye is
released [8]. However, similar to the acid phosphatase test,
the Phadebas assay is an indirect test that measures the
activity of amylase. Therefore, these biochemical tests
sometimes lack specificity because they cannot differentiate
between the alpha-amylase 1 (present in saliva) and alpha-
amylase 2 (present in semen and vaginal secretion) [9, 10].
In general, color-based presumptive tests (Phadebas, SALI-
gAE test) can be challenging to interpret for weak to trace
positives or for mixtures with blood [11].
The main disadvantage of these biochemical tests is their
destructive nature, resulting in sample loss for subsequent
DNA analysis [12]. Since forensic samples are often found
in low quantity, destruction of DNA should be avoided.
Another disadvantage of the current biochemical tests is
their specificity for only one biological matrix [1–3,
12–14]. This means that several cascade tests might be
needed before the biologic nature of a certain sample or
stain is uncovered. Also, when the identity of one biological
matrix is determined, no or little effort is made to find out if
the sample is a mixture of different biological matrices. This
is due to the high cost of the tests, the fact that cascade
testing is very time consuming and the increased loss of
sample when multiple tests are performed [15].
Besides the identification of a certain biological matrix,
determining the species of the donor of the sample can be
equally important. For example, benzidine testing is used to
determine the presence of blood, but to distinguish human
blood from animal blood, other tests such as the hexagon-
Obti test are needed [14, 16]. In addition, these tests can
only indicate the presence or absence of blood from one
specific species. If negative, another test has to be per-
formed in order to potentially identify what animal species
the blood originated from.
Therefore, forensic science calls for a universal, specific,
and unbiased method that can identify pure as well as
mixtures of biological matrices of different species origin
without destruction of the DNA and preferably without any
additional sample consumption, so that the full trace is
available for DNA extraction.
Here, we present a mass spectrometry (MS)-based
approach that can fulfill these requirements. In order
to validate the use of mass spectrometry for the deter-
mination of biological matrices in forensic science, we
first constructed a decision tree based on the specific
and most prominent proteins present in biological ma-
trices that might be found at a crime scene (blood,
saliva, sperm, vaginal fluid, nasal secretion, feces, and
urine). For the detection of semen, we focused on
proteins present in the seminal fluid [4, 5, 12]. In this
way, our approach could also be used to detect semen
from men having undergone a vasectomy.
After the construction of a decision tree, the bio-
markers for the most commonly encountered biological
matrices in forensics (blood, semen, vaginal fluid, sali-
va) were evaluated in a blind analysis and all samples
were annotated correctly, except when low amounts of
saliva or vaginal fluid were present in combination with
high amounts of blood or semen. Next, dilution series
for saliva, blood, and semen proved our method equally
or even more sensitive compared to other, biochemical
methods. The MS approach could also detect semen on
vaginal swabs 24 to 36 h after a possible rape. Addi-
tionally, species identification was validated on human,
canine, and bovine blood. Finally, our decision tree was
validated on real forensic samples. Constructing this
methodology required a great amount of laboratory ex-
pertise, but new approaches in the field such as SRM
(selected reaction monitoring) and library search algo-
rithms are increasingly making MS-based detection
methods accessible to a broader community. Therefore,




Different biological matrices were applied on sterile
cotton-tipped swabs. The swabs were dried for 3 h at
room temperature and stored at −20°C. For the valida-
tion of biomarkers, different biological matrices were
applied, either alone or in mixtures (Table 1), on a
piece of cotton clothing which was first rubbed on
hands and arms to contaminate the fabric with human
keratins. Additionally, the fabric was deliberately soiled
with dirt on shoes and floor to mimic real life samples.
The different spots were dried for 1 h.
Before protein extraction, the swabs and the fabric were
thawed, cut, and transferred into LoBind Eppendorf tubes
(Eppendorf AG, Hamburg, Germany). After adding 500 μL
of ultrapure water (MilliQ, Merck Millipore, Billerica, MA,
USA), the Eppendorf tubes were vortexed thoroughly and
the samples were incubated for 30 min at room temperature.
Subsequently, the Eppendorf tubes were centrifuged for
5 min at 14,000×g. Since this procedure is the first step of
the chelex DNA extraction, the pellet can be used for DNA
analysis [17]. The supernatant is normally thrown away.
Here, it is stored at −20°C and is later used for MS analysis.
The validation experiment was blind, meaning that the
identity of the biological matrices in the different spots was
not known to the investigator.
Int J Legal Med
Table 1 List of biological fluids and mixtures used in the blind experiment






Z1 Semen Semenogelin-1 39 1,094 1.1e−008
Semenogelin-2 30 1,009 3.7e−012
Prostatic acid phosphatase 4 156 1e−005
Prostate-specific antigen 1 82 4.1e−006
Z2a Vaginal secretion Cornulin 1 81 5.2e−006
Z2 bb Vaginal secretion Cornulin 4 239 8.4e−008
Cornifin 2 130 2.4e−008
Z3 Bovine blood Hemoglobin subunit beta OS0Bos taurus 27 904 1.3e−007
Hemoglobin subunit alpha OS0Bos taurus 15 847 4.5e−014
Z4 Human blood Hemoglobin subunit beta 24 905 5.4e−010
Hemoglobin subunit alpha 7 348 1.8e−007
Z5a Saliva Alpha-amylase 1 1 63 0.00034
Z5 bb Saliva Alpha-amylase 1 14 813 3.8e−011
Z6 Semen Semenogelin-2 35 1,158 2.3e−009
Semenogelin-1 32 828 6.9e−009
Prostatic acid phosphatase 3 179 1.9e−007
Prostate-specific antigen 2 113 1.5e−005
W Semen, vaginal secretion Semenogelin-2 21 737 1.3e−009
Semenogelin-1 24 659 5.7e−006
Cornulin 5 656 1.9e−022
Prostatic acid phosphatase 1 89 8.3e−007
Cornifin-B 2 84 0.00074
Involucrin 1 46 0.018
X1 No biological matrix /
X2 Semen, human blood Hemoglobin subunit beta 36 1,203 5.6e−010
Hemoglobin subunit alpha 16 795 9.3e−017
Semenogelin-2 6 271 2.2e−009
Semenogelin-1 2 76 0.00016
X3 Human blood Hemoglobin subunit beta OS0Homo sapiens 10 254 9.5e−008
Hemoglobin subunit alpha OS0Homo sapiens 6 254 8.8e−008
X4 Semen, saliva Semenogelin-2 35 1,793 8.1e−023
Semenogelin-1 41 1,337 2.2e−015
Alpha-amylase 6 244 6e−010
Prostate-specific antigen 5 207 3.5e−006
Prostatic acid phosphatase 5 205 1.7e−007
X5 Human blood, saliva Hemoglobin subunit beta 39 1,187 5.9e−010
Hemoglobin subunit alpha 15 807 2.6e−018
Alpha-amylase 1 3 129 1.4e−005
X6 Bovine blood, saliva Hemoglobin subunit beta OS0Bos taurus 24 860 1.3e−007
Hemoglobin subunit alpha OS0Bos taurus 13 787 1.3e−015
Alpha-amylase 1 3 160 3.1e−007
X7 Semen, vaginal secretion Semenogelin-2 25 891 4.3e−010
Semenogelin-1 28 712 9.4e−007
Cornulin 2 219 1.9e−012
Prostatic acid phosphatase 5 201 1e−007
The annotations were performed with Mascot Daemon. The number of identified peptides, the protein score, and the maximal expectancy are
indicated as well
a 1/10 of the sample gave a low number of peptides after MS analysis (n=1)
b 1/2 of the sample was used for MS analysis
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All volunteers who donated biological fluids consented
to participation in the study.
Sensitivity of the MS approach
Different dilutions of saliva (1:2, 1:3, 1:4, 1:5, 1:10, 1:100,
1:200, 1:500, 1:1,000; n03), human blood (1:10, 1:100,
1:1,000, 1:10,000, 1:100,000, 1:1,000,000; n03) and semen
(1:10, 1:100, 1:1,000, 1:10,000, 1:100,000, 1:1,000,000; n0
3) were made in Eppendorf tubes with ultrapure water. Then
100 μL of the diluted saliva, 40 μL of the diluted blood, and
200 μL of the diluted semen were analyzed by means of the
MS approach. The same volume of each dilution was used
for the conventional biochemical methods. For saliva,
100 μL of the dilution was applied on cotton swabs and
dried prior to the Phadebas test (Magle AB, Lund, Sweden).
For blood, 40 μL of the dilution was applied on filter paper
for the benzidine test. For semen detection, 200 μL of the
dilution was directly applied on the Seratec PSA semiquant
test (Seratec, Göttingen, Germany) for PSA detection, and
for acidic phosphatase (AP) detection, 200 μL was applied
on a piece of cotton fabric, dried, and analyzed with the
Phosphatesmo Km Paper kit (Macherey-Nagel GmbH &
Co., Düren, Germany). All the conventional tests were
performed by trained experts according to the manufacturer’s
protocols.
To validate the use of MS to find traces of semen on
different time lapses after a rape, vaginal swabs were taken
12 h, 24 h, 36 h, 48 h, 60 h, and 72 h after sexual intercourse
(n03). All swabs were analyzed as described above and
compared with the Seratec PSA semiquant test for semen
detection.
Forensic samples
Real forensic samples (n012) were also analyzed to confirm
the applicability of this technique in a real-world setting.
Small pieces of fabric (0.5 cm²) were cut out from under-
wear or other clothing that was available from five different
rape cases and divided in two: one part was tested for PSA
or AP by means of conventional biochemical tests and the
other part was used for mass spectrometric analysis. To this
end, the pieces of clothing were incubated in 500 μL ultra-
pure water for 30 min as described above. One tenth of the
sample was injected for mass spectrometric analysis. Addi-
tionally, seven other forensic samples that were positive for
blood after a benzidine test were analyzed with MS.
In solution digest
One twenty-fifth of the supernatant from the swabs with
only one biological matrix was used to determine possible
biomarkers, while 1/10 of the supernatant was used for the
other samples (possible mixtures of biological matrices on
the dirty fabric and forensic samples). Analysis of a higher
amount of proteins for the samples from the dirty fabric and
for the forensic samples is recommended since identification
of biomarkers in these samples can be hampered by inter-
fering proteins or dirt. For the blind samples with known
proportions, a mixture of 100 μL was prepared and 1/100 of
the sample was analyzed. Samples with a low number of
identified peptides were rerun in a larger sample size [9/10
instead of 1/10 (Table 1) or 1/2 instead of 1/100 (Supple-
mentary Table S2)]. Dried supernatant or dried body fluid
mixtures were dissolved in 20 μL 0.5 M triethylammonium
bicarbonate (TEABC; Sigma-Aldrich, St. Louis, MO,
USA). One microliter of denaturant (2 % SDS; MP, Illkirch,
France) and 2 μL reducing agent [50 mM tris-(2-carboxye-
thyl)phosphine (TCEP; Sigma-Aldrich, St. Louis, MO,
USA)] were added to each Eppendorf and incubated for
1 h at 60°C. Subsequently, 1 μL of alkylizing agent
[200 mM methyl methanethiosulfonate (MMTS; Sigma-
Aldrich, St. Louis, MO, USA)] was added. After a 10-min
incubation at room temperature, the proteins were digested
overnight at 37°C with 1 μg of trypsin (Promega, Madison,
WI, USA). The resulting peptides were dried and stored
at −20°C.
Mass spectrometric analysis
Dried peptides were dissolved in 40 μL 0.1 % formic acid
(FA) in water (buffer A) and 20 μL was desalted after
injection on a Acclaim PepMap 100 C18 pre-column
[0.3 mm internal diameter (i.d.)×5 mm, 5 μm particle size;
Dionex, Sunnyvale, CA, USA] with buffer A. Separation
was performed by means of reversed phase nano-HPLC
(Pepmap C18 column 15 cm, particle size 3 μm, 0.3 mm
internal diameter by 150 mm; Dionex, Sunnyvale, CA,
USA) at 60°C using a linear gradient of 97:3 buffer A/buffer
B to 20:80 buffer A/buffer B at 300 nL/min over 70 min
(buffer B—80 % ACN/0.1 % FA). The different peptides
were analyzed on an ESI Q-TOF Ultima (Waters, Milford,
MA, USA) in a data dependent mode, where automatically
switching between MS and MS/MS occurred on up to seven
higher charge ions, when the intensity of the individual ions
rose above 50 counts per second. The fluid was dispersed at
a voltage between 1,800 V and 2,200 V (capillary voltage)
and the cone voltage was set at 100. The source temperature
was 95°C, while the dissolvation temperature was set at
120°C. m/z ratios were selected for MS between 450 and
1,650. MS/MS spectra were acquired between 50 and
2,300 Da. Ions were fragmented by collision induced disso-
ciation, with a custom collision energy profile for LC–
MSMS samples, ranging from 25 eV to 55 eV for doubly
charged peptides between m/z 400 and 1,200, and ranging
from 11 eV to 26 eV for triply charged peptides between m/z
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435 and 1,000. m/z ratios selected for MS/MS were exclud-
ed for 150 s. Data were searched against Swissprot database
of Mammalia using the in-house search engine Mascot
Daemon (2.3; Matrix Science, London, UK). Methylthio
(C) was specified as fixed modification since this modifica-
tion was added to the peptides through alkylation by means of
MMTS during the digest protocol. Oxidation (M) and deami-
dation (NQ) were considered as variable modifications since
these are very common modifications on proteins/peptides
[18–20].
The peptide tolerance and MS/MS tolerance were set to
0.35 Da and 0.6 Da, respectively. A maximum of two
missed cleavages were allowed. To filter out homologous
proteins, only the proteins with at least one bold red peptide
in Mascot Daemon were used. Red indicates the top scoring
peptide match for this spectrum and bold indicates that it is
the highest scoring protein this peptide match is found in.
By dropping hits that have no bold red matches, we can thus
largely eliminate homologues with lower coverage [18]. In
general, the identification threshold was set at a p value of
0.05 per peptide. The p value is the probability of a false
positive annotation of a peptide. For the determination of the
biomarkers, we decreased the p value to 0.01 to make sure
that the identified proteins were not derived from false
positive annotations of peptides. Searches were performed
with trypsin as enzyme. For urine and feces, searches were
performed with both trypsin and semitrypsin. The number of
identified peptides is mentioned as a rough estimate of the
abundance of this protein in the sample. The score of a
peptide is a measure for the quality of the spectrum obtained
after MSMS (threshold was set at 41) and the score of a
protein is the sum of scores of all peptides annotated for that
protein. Note that the p value can only be calculated for one
peptide and not for the whole protein [18]. The p values in
the tables are thus a measure for the false discovery rate of
the best annotated peptide. The basic principles on proteo-
mics and mass spectrometry are reviewed in [21, 22]. Au-
tomation of this approach will no longer require the
interpretation of these scoring algorithms. The workflow
of the mass spectrometric approach for the identification of
biological matrices is depicted in Fig. 1.
Results and discussion
Biomarkers of fluid biological matrices
Nine biological matrices from different individuals [human
blood (n05), animal blood (bovine and canine; n04), hu-
man menstrual blood (n03), semen (n02), vaginal fluid (n0
4), saliva (n02), nasal secretion (n05), feces (n04), and
urine (n06)] were applied on sterile swabs in order to
identify possible biomarkers. Supernatant of these samples
were digested in peptides and used for mass spectrometric
(MS) analysis. Per biological matrix different proteins were
identified (p<0.01) (Supplementary Data Table S1).
Our selection criteria for biomarkers were based on the
specificity and the abundance of the protein. Since the
amount of biological matrix in forensic samples can be
low, it has no use to incorporate biomarkers that can hardly
be detected. Therefore, we chose our biomarkers from the
highly abundant proteins.
For blood, hemoglobin (alpha and beta subunit) was
chosen as biomarker since this protein was specific for
blood and present in large amounts (Supplementary Data
Table S1) [14, 16]. Mass spectrometry has already been
used to identify hemoglobin variants in blood [23]. Addi-
tionally, hemoglobin is not only very specific and highly
abundant in blood but it also allows to distinguish between
different species of origin. Espinoza et al. found that hemo-
globin, analyzed by electrospray ionization mass spectrom-
etry, can resolve species by the presence of species
determining peptides [24]. Despite extensive homology, all
three species tested (Homo sapiens, Canis familiaris, and
Bos taurus) were unambiguously annotated based on highly
confident identification of species-specific peptide stretches.
The hexagon Obti test that is most commonly used to
determine human origin of blood stains can differentiate
between human and non-human blood, but MS can easily
pinpoint the species as well, again without any loss of trace
or cellular material needed for subsequent DNA analysis.
By means of mass spectrometry, semenogelin 1 and 2 but
also other semen-specific proteins such as prostatic acid
phosphatase and PSA were found (Fig. 2). By means of
Fig. 1 Workflow for mass
spectrometric identification of
biological matrices
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Fig. 2 Decision tree
with biomarkers per biological
matrix. *The absence of the
biomarker (uromodulin/AMBP
protein or immunoglobulins)
does not necessarily exclude the
presence of the matrix (urine
or feces, respectively)
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the MS approach, these different proteins are often detected
in one single test and in this way the presence of different
semen proteins further confirms the origin of the matrix.
Vaginal biomarkers are cornulin, involucrin, and cornifin
while alpha-amylase 1 is the highly abundant and specific
protein for saliva. By means of mass spectrometry, a dis-
tinction between the two forms of alpha-amylase (alpha-
amylase 1, present in saliva and alpha-amylase 2, present
in semen and vaginal secretion) can be made, thus increasing
specificity.
In menstrual blood, the biomarkers from both blood and
vaginal secretions were present: hemoglobin and cornulin.
For nasal secretions, albumin, immunoglobulins (Ig alpha-
chain, Ig kappa chain C region, J chain) and plunc protein
were detected. The latter was specific for this matrix [25, 26].
In urine, a few proteins/peptides could be detected: albu-
min, AMBP protein, and uromodulin. These proteins have
already been detected previously [27–29]. Albumin is found
in high amounts in blood as well and can therefore not be
used as biomarker. Uromodulin, on the other hand, is the
most abundant protein in normal human urine [30]. It should
be noted that it can also be detected in serum [31]. However,
when no hemoglobin is found in a sample, we can exclude
blood as biological fluid. In this way, uromodulin can serve
as a biomarker for urine in the absence of the manifold more
abundant hemoglobin that would show up when blood is
present. Similarly, the presence of AMBP protein in the
absence of hemoglobin can be used as a marker for urine.
However, the absence of uromodulin or AMBP protein does
not mean that no urine is present since in some urine
samples no proteins or peptides could be detected, probably
due to their low concentration.
For feces, immunoglobulins (J chain, Ig kappa chain C
region, and Ig alpha chain) could be detected in some
samples (two out four samples). However, immunoglobu-
lins are not ideal biomarkers for the identification of biolog-
ical matrices since these proteins are also found in other
matrices such as blood. Still, the presence of immunoglo-
bulins and/or albumin in the absence of hemoglobin can
indicate the presence of feces and excludes the presence of
blood. Therefore, a feces trace will not be mistaken for a
blood trace, but mixtures of blood and feces will be hard to
identify as a mixture. A decision tree with biomarkers for
different biological matrices is depicted in Fig. 2.
Blind testing and annotation of fluid biological matrices
In order to evaluate our list of biomarkers, the most relevant
biological matrices in forensic casework (human blood,
non-human blood, semen, saliva, and vaginal secretions)
were applied on a dirty cotton fabric in order to mimic
real-life situations. Since the biomarkers for urine and feces
could not always be detected and since urine, feces, and
nasal secretions are seldom crucial in forensic casework, we
did not incorporate them in further analyses.
Mixtures of several biological matrices were also includ-
ed as this often occurs in real casework (Table 1). A major
advantage of this unbiased MS approach is the ability to
annotate different proteins at the same time, making it
possible to identify several biological matrices in one sam-
ple with only one test. This equally makes cascade testing
redundant. Additionally, different markers for the same ma-
trix such as semenogelin and PSA for semen can be used as
a confirmation of the identity of that matrix.
During this analysis, no information on the presence of
biological fluids or the presence of mixtures was available to
the investigator. Samples Z2 and Z5 showed a relatively low
number of peptides. Therefore, these samples were rerun
with 1/2 of the sample instead of 1/10. All identifications
were correct, which clearly demonstrates the robustness and
specificity of our decision tree.
Additionally, we tested these matrices in different pro-
portions and applied 1/100 of the sample on the mass
spectrometer (Supplementary Data Table S2). Moreover, 1/
100 of the sample was used since the amount of biological
fluid to make these samples was much higher than the
amount present in forensic samples (see “Materials and
methods”). It should be noted, however, that one sample
(S3) showed a low number of peptides. Therefore, 1/2
instead of 1/100 of this sample was rerun on the mass
spectrometer. All four matrices were correctly annotated,
including low amounts of blood and semen in high amounts
of another biological matrix. However, low amounts of
saliva and vaginal fluid, two matrices with low protein
concentrations, could not be detected when mixed in high
amounts of blood and semen, the matrices with high protein
concentrations.
All identifications with a score above 41, which is corre-
lated with a p value below 0.05, are mentioned in the table
(Table S2). It is worth mentioning that in sample S5, prostatic
acid phosphatase (one peptide, score 38, maximum p value of
0.071) could also be detected. This peptide had a score below
the threshold, but it can be seen as a confirmation of semen by
means of semenogelin detection. Similarly, prostatic acid
phosphatase (two peptides, score 32, maximum p value
0.39) and prostate-specific antigen (one peptide, score 35,
maximum p value 0.22) were also found in sample S10.
Sensitivity of the mass spectrometric approach
In order to determine the sensitivity of the mass spectromet-
ric approach, we made dilutions of the biological fluids of
interest. For semen, saliva, and blood, these sensitivities
were compared with the conventional biochemical methods
(Seratec PSA semiquant test for PSA and the Phosphatesmo
Km Paper kit for AP were used for semen, benzidine for the
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detection of blood, and the Phadebas test for saliva) for
samples from three different volunteers per biological ma-
trix. The MS approach showed comparable or even higher
sensitivity when compared to the currently used biochemi-
cal tests. The maximum sensitivity of the benzidine test was
1:10,000 in our laboratory, while mass spectrometry showed
a sensitivity of 1:100,000 starting from the same amount of
sample. However, it should be noted that luminol has also
been reported with a sensitivity of 1:100,000 [1]. For saliva,
a maximum sensitivity of 1:100 for the Phadebas test was
observed in our laboratory. The MS approach reveals a
maximum sensitivity of 1:1,000. For semen, a higher spec-
ificity compared to the AP test (1:100) and a comparable
sensitivity compared to the PSA test (1:100,000) was found
by means of MS (maximum sensitivity of 1:100,000). Taken
together, the sensitivity of the mass spectrometric approach
is comparable to the conventional methods or even exceeds
their performance.
Since forensic science is often used to solve rape cases, a
time-lapse experiment was also conducted to determine the
sensitivity of post-coital sperm detection. After sexual inter-
course, a vaginal swab was obtained from three volunteers
every 12 h. By means of MS, the presence of semen
(semenogelin) could still be detected after 24 h (n03) or
even after 36 h (n02). When using the same amount of
sample, the Seratec PSA semiquant test could only detect
semen up to 12 h after intercourse in all three volunteers.
Annotation of forensic samples
As a final validation of our approach, we analyzed real
forensic samples from actual cases. Five different rape cases
with semen on clothing were analyzed with the conventional
methods to detect semen. For MS analysis, only the super-
natant was analyzed while the pelleted cells were used for
DNA profiling. Not only in recent samples (2010 and 2011)
but also in 5–8-year-old samples (a sample of 2006 and a
sample of 2003) semen and/or vaginal fluid could be
detected by means of the MS approach. A forensic sample
with semen on a sweater revealed the presence of semen
(semenogelin, PSA) and the absence of vaginal fluid (no
involucrin, cornulin, or cornifin) (Table 2). Interestingly,
alpha-amylase 1 was also detected, which revealed the pres-
ence of saliva. The latter was not determined by the con-
ventional method because after identification of one
biological matrix (such as semen in a rape case), testing is
usually abrogated.
Besides rape cases, real forensic samples with possible
blood stains were included as well. Supernatants from stains
(max 1 year old) that were positive for blood with the
conventional test (benzidine) were analyzed by means of
mass spectrometry. In each sample, hemoglobin was
detected (Table 3), again illustrating the usefulness of mass
spectrometry for identification of the biological fluids in
forensic caseworks.
We also tested the potential of the approach to discrimi-
nate animal traces in real forensic samples. In the stomach of
a corpse, brains were found, but no information was known
on the species identity. MS analysis revealed the presence of
canine hemoglobin (two peptides, maximum p value0
0.0003, score064), indicating that the brains originated
from dogs. In another case, blood was found on the floor
at a crime scene, but no DNA profile could be obtained. By
means of this MS approach, we found that the blood
Table 2 Detection of biological matrices on forensic samples from rape cases, with their number of identified peptides, the score, and maximum p
value from Mascot Daemon




Washcloth (6 months) Semenogelin-1 Sperm 4 174 1e−005
Women’s sweater (1 year) Semenogelin-2 Sperm 19 819 4.6e−017
Semenogelin-1 15 630 2.7e−015
Prostatic acid phosphatase 4 125 0.00029
Alpha-amylase 1 Saliva 2 197 2.8e−015
Women’s underpants (2 years) Prostatic acid phosphatase Sperm 1 73 3.5e−005
Cornifin-A Vaginal fluid 3 44 0.03
Women’s underpants (5 years) Semenogelin-2 Sperm 18 510 2.9e−008
Semenogelin-1 20 492 4.3e−008
Prostatic acid phosphatase 5 152 4e−005
Prostate-specific antigen 1 72 4.9e−005
Cornulin Vaginal fluid 1 91 5.3e−007
Women’s underpants (8 years) Prostate-specific antigen Sperm 4 182 3.2e−007
Cornulin Vaginal fluid 1 67 0.00015
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originated from a dog (11 peptides from hemoglobin beta,
origin C. familiaris, score of 288, maximum p value of
6.6e−006; four peptides from hemoglobin alpha, origin C.
familiaris, score of 181, maximum p value of 3.2e−010).
Biological matrix identification in practice
To further optimize this approach for implementation, auto-
mated digestion can be used to diminish the workload: shorter
digestion times have already been described (2.5 s–7.5 min)
and will dramatically decrease the sample preparation time
[32, 33]. Data analysis can be simplified by developing a
selected reaction monitoring (SRM) workflow on proteotypic
peptides [34]. Importantly, the use of MS analysis in forensics
has the additional advantage that every peptide identification
is linked with a p value. Thus, the certainty about the identity
of a sample can be translated into a probability, while inter-
pretation of biochemical tests can be subjective when low
amounts of sample are present. This p value can more easily
be used in court, as is currently done for presenting DNA
typing results. It should be noted, however, that the algorithm
calculates these probabilities for each separate MSMS spec-
trum (peptide) as independent p values and that these cannot
simply be transposed to a probability of the protein identifi-
cation as a whole. This means that the easiest way to present
statistical data is by presenting the best peptide hit if the p
value is very low. On the other hand, a protein that is identified
by three different peptide stretches of each p00.05 should be
seen as a very strong indication of the presence of the protein.
This expert data handling, however, is expected to be over-
come following future automation steps.
Notably, this approach was optimized and validated in
parallel with chelex extraction for DNA typing. Other DNA
extraction kits, based on silica for example, were not tested,
but since our approach is performed on the extracellular
proteins, which can easily be isolated in advance, the
DNA extraction procedure has no influence on the MS
results.
The use of mass spectrometry in forensic science has
been reported before, mainly in toxicology studies, such as
the detection of opioids or ephedrines [35–37]. But mass
spectrometry can also differentiate between different sour-
ces of the same material based on their isotope ratio [38] and
can be used for genotyping and the determination of single
nucleotide polymorphisms [39–41]. However, to the
authors’ knowledge, this is the first study that highlights
the use of mass spectrometry to identify biological matrices
in forensic science.
Mapping the MS approach in current forensic sciences
Besides mass spectrometry on proteins, other techniques
have been suggested to identify the matrix and the species
it is derived from. Techniques focusing specifically on
mRNA, miRNA, and DNA methylation, but also more
general detection methods such as fluorescence spectrosco-
py and RAMAN spectroscopy, have proven useful in the
field. Species identification by means of mRNA markers
relies on the unique expression of mRNA to identify body
fluid stains [15, 42, 43]. However, cross-reactivity is still an
issue with this technique and novel mRNA markers for all
body fluids are needed to increase the discriminatory power
of the assay. To the author’s knowledge, no clear consensus
on the choice of mRNA markers has currently been
achieved [42]. Additionally, the stability of mRNA can lead
to problems in the forensic context [44, 45]. Therefore, a lot
Table 3 Detection of blood
on forensic samples by means of
mass spectrometry
The number of identified
peptides, the score, and the maxi-
mum p value from Mascot
Daemon are indicated as well





Swab from car door Hemoglobin subunit beta 36 968 1.3e−012
Hemoglobin subunit alpha 25 818 6.1e−011
Swab from car door Hemoglobin subunit beta 6 140 3.4e−006
Hemoglobin subunit alpha 3 53 0.037
Swab from stain on back
of envelope
Hemoglobin subunit beta 7 127 1.6e−005
Hemoglobin subunit alpha 4 93 7.6e−007
Swab, origin unknown Hemoglobin subunit beta 32 905 3e−013
Hemoglobin subunit alpha 18 584 7.1e−013
Swab from a sweater Hemoglobin subunit beta 16 555 1.2e−013
Hemoglobin subunit alpha 13 358 2.6e−008
Swab from stain on envelope Hemoglobin subunit beta 43 838 2.4e−010
Hemoglobin subunit alpha 16 354 7.2e−007
Swab from shower Hemoglobin subunit beta 39 768 4.9e−010
Hemoglobin subunit alpha 23 479 2.6e−011
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of attention is currently paid to microRNA (miRNA) as a
tool to identify biological matrices. Because of their small
size, they are less prone to degradation, unlike the larger
mRNAs [46, 47]. Hanson et al. were the first to use miRNA
profiling as an alternative approach to body fluid identifica-
tion in forensic casework. They found a panel of nine
miRNA that allowed them to differentiate between blood,
semen, saliva, vaginal secretions, and menstrual blood.
However, no strong miRNA candidate was found for semen.
It should be noted that a more recent study by Zubakov et al.
could not reproduce these results [47]. Possible explanations
are the difference in strategy for both cDNA synthesis and
PCR quantification, and also the natural variation in miRNA
expression between individuals. So, rigorous methodological
validation and standardization are crucial.
miRNA can be used to test different biological matrices in
one sample, but the detection of each miRNA must be per-
formed in different wells and thereby in different analyses.
Multiplexing is possible but is limited due to the limited
number of dyes available for use in QT-PCR assays [48]. By
means of the MS approach, no multiplexing is necessary since
all biological matrices can be analyzed in one single run.
Recently, Frumkin et al. reported a new method to iden-
tify forensic tissue based on methylation of DNA [49, 50].
This technique based on tissue-specific methylation patterns
has a lot of advantages since it gives operator-independent
results, similar to the MS approach, and can be multiplexed
with existing STR typing protocols without additional sam-
ple loss. Importantly, this technique is still cell-based, which
makes it unsuited for detecting sperm from men with a
vasectomy and implying a need for more DNA for multi-
plexing (1 ng versus 100 pg necessary for a good DNA
profile) [51]. Frumkin et al. also rightfully state that the loss
of function of proteins can lead to false negatives in the
current protein-based commercial kits [49]. However, the
primary structure of proteins is extremely stable and its
sequence can still be identified by means of mass spectrom-
etry after hundreds of years [52], which makes them per-
fectly suited for forensic science.
Fluorescence spectroscopy can also be used for forensic
casework, but despite its good sensitivity, questions arise
about its specificity because the fluorescence emission
peaks are very broad [12]. This also makes it harder to
identify possible mixtures of biological fluids. Finally,
RAMAN spectroscopy, based on scattering of light, has a
higher specificity since very narrow peaks are formed.
However, its sensitivity is lower. RAMAN can identify
mixtures and is able to distinguish human from canine
semen [53], but no difference between cat, dog, and human
blood was found in that study [14]. By means of mass
spectrometry, on the other hand, high sensitivity and spec-
ificity can be obtained and species identification can be
performed at the same time.
Our MS method has therefore a lot of advantages, but it
should be noted as well that at this moment it is not suited to
replace the current (colorimetric, enzymatic,…) methods to
identify biological matrices in forensic science. Although
the protocol for this method is easy to perform, it takes
longer before obtaining results compared to the current
biochemical tests. Despite the fact that portable mass spec-
trometers are already available, tissue identification at a
crime scene is not feasible at the moment. However, there
is no doubt that this technique is useful as an additional
method and that it can be adapted in the future for easier
application.
In conclusion, by means of this MS-based proteomics
approach, we were able to distinguish all the frequently pre-
sented samples in forensic casework (vaginal fluid, semen,
saliva, and blood) as well as mixtures thereof and could easily
annotate animal contamination. The major advantage of this
technique is the fact that the analysis is not destructive for
DNA since it is performed on the supernatant of the sample,
which is otherwise discarded, so the pellet can still be used for
DNA typing. Therefore, this technique can be used either as
an exploration or as a confirmation technique, when questions
arise upon the identity of the biological matrix after DNA
profiling in combination with traditional screening tests. Ad-
ditionally, by means of MS, species annotation and identifi-
cation of the biological matrix can be performed in one single
test instead of cascade testing. This is of major importance as
more often than not these traces are scarce on a crime scene.
Finally, the high sensitivity of this approach and the stability
of proteins make this method fitted to identify both small and
old samples.
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